An inactive metabolite of baclofen
Related Products
Parent Compound(s)
18600(±)-Baclofen
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

3-(4-Chlorophenyl)-4-hydroxybutyric Acid (sodium salt)

Item No. 21483

Technical Information
Formal Name
4-chloro-β-(hydroxymethyl)-benzenepropanoic acid, monosodium salt
CAS Number
1346603-21-1
Synonyms
  • γ-Hydroxybaclofen
Molecular Formula
C10H11ClO3 • Na
Formula Weight
Purity
≥98%
A solid
Methanol: solubleWater: soluble
SMILES
ClC1=CC=C(C(CC(O)=O)CO)C=C1.[Na]
InChi Code
InChI=1S/C10H11ClO3.Na/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14;/h1-4,8,12H,5-6H2,(H,13,14);
InChi Key
PKWMRTYJSOAALK-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    3-(4-Chlorophenyl)-4-hydroxybutyric acid is an inactive metabolite of the GABAB receptor agonist baclofen (Item No. 18600).1,2,3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wuis, E.W., van Beijsterveldt, L.E., Dirks, R.J., et alRapid simultaneous determination of baclofen and its γ-hydroxy metabolite in urine by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 420(1), 212-216 (1987).

    2. Chéramy, A., Nieoullon, A., and Glowinski, J. Effects of the unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat. Eur. J. Pharmacol. 58(2), 133-140 (1979).

    3. Ault, B., and Evans, R.H. The depressant action of baclofen on the isolated spinal cord of the neonatal rat. Eur. J. Pharmacol. 71(4), 357-364 (1981).